about
Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer.Hypoxia modulates the phenotype of osteoblasts isolated from knee osteoarthritis patients, leading to undermineralized bone nodule formation.Identification of hypoxia-regulated proteins using MALDI-mass spectrometry imaging combined with quantitative proteomics.LOXL2-mediated matrix remodeling in metastasis and mammary gland involution.LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling.Hypoxia-mediated metastasis.Quantification of Lung Metastases from In Vivo Mouse Models.Altered Structural Expression and Enzymatic Activity Parameters in Quiescent Ulcerative Colitis: Are These Potential Normalization Criteria?Circadian control of the secretory pathway maintains collagen homeostasis
P50
Q33688524-8D2AD78B-9464-4708-BE05-0585451DC903Q34806346-A387E9E7-A8A6-43EA-9781-69275FBD681CQ35139526-B57AAAE1-CAF7-40D0-BD81-E88544A11217Q37346579-7490654A-C280-49FC-B64D-9CD7A18174DFQ37690525-A814AECE-4128-4BAA-8AD3-17FDB5A4743DQ38165835-FEF0BA26-3E84-4AB7-A315-16D3BA51D4CAQ39668596-38599535-5AD3-4C17-93F3-9A4A11BF36B1Q90269881-C5AE4CBC-25E1-4A24-B4EF-06169551AD5AQ92453662-E84D2528-F05D-41BC-AFD6-BE6E541BDE41
P50
description
researcher ORCID ID = 0000-0002-7283-9759
@en
wetenschapper
@nl
name
Joan Chang
@ast
Joan Chang
@en
Joan Chang
@es
Joan Chang
@nl
type
label
Joan Chang
@ast
Joan Chang
@en
Joan Chang
@es
Joan Chang
@nl
prefLabel
Joan Chang
@ast
Joan Chang
@en
Joan Chang
@es
Joan Chang
@nl
P31
P496
0000-0002-7283-9759